Archives

Cellular Intelligence, an AI-native TechBio, Enters Agreement with Novo Nordisk to Advance Clinical-Stage Parkinson’s Cell Therapy

B Cellular Intelligence has secured global rights to Novo Nordisk’s Parkinson’s program, a clinical-stage allogeneic cell therapy for Parkinson’s disease with FDA Fast Track Designation.… Login to continue reading Login…

Read MoreCellular Intelligence, an AI-native TechBio, Enters Agreement with Novo Nordisk to Advance Clinical-Stage Parkinson’s Cell Therapy

FarmaMondo Group appoints Independent Board Director Natalie Douglas, global pharmaceutical managed access and commercialization pioneer

B PRINCETON, N.J. and CHIASSO, Switzerland, May 11, 2026 /PRNewswire/ — FarmaMondo Group, an international commercial pharmaceutical organization that partners with pharma and biotech to… Login to continue reading Login…

Read MoreFarmaMondo Group appoints Independent Board Director Natalie Douglas, global pharmaceutical managed access and commercialization pioneer

Apnimed Announces Three Oral Presentations and a Late-breaking Poster at the American Thoracic Society (ATS) 2026 International Conference

B CAMBRIDGE, Mass., May 11, 2026 /PRNewswire/ — Apnimed, Inc., a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral… Login to continue reading Login…

Read MoreApnimed Announces Three Oral Presentations and a Late-breaking Poster at the American Thoracic Society (ATS) 2026 International Conference